Skip to Main Content

Paper Details

Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
Eur Heart J
12
2023
Dapagliflozin, Heart Failure, Patients, cardiovascular death, dapagliflozin, furosemide, heart failure, patients
Author NameAffiliation
Akshay S DesaiBrigham and Women's Hospital, Harvard Medical School
Rudolf A de BoerErasmus Medical Center
Carolyn S P LamNational Heart Centre Singapore & Duke-National University of Singapore
Mikhail KosiborodSaint Luke's Mid America Heart Institute and University of Missouri-Kansas City
Adrian F HernandezDuke University Medical Center
  • 1 - 5

Datasets

Release 1.2